Does administration of 6 units of human Actrapid (regular insulin) cause a decrease in blood glucose?

Yes, 6 units of human Actrapid (regular insulin) will cause a decrease in blood sugar.

Actrapid is regular human insulin, and its primary pharmacological action is to lower blood glucose by facilitating cellular uptake of glucose and inhibiting hepatic glucose production. The dose of 6 units is clinically meaningful and will produce a measurable hypoglycemic effect.

Mechanism and Expected Effect

Regular human insulin like Actrapid works by:

• Promoting glucose uptake into muscle and adipose tissue
• Suppressing hepatic glucose output
• Inhibiting lipolysis and proteolysis

The magnitude of blood glucose reduction depends on several critical factors:

Key Variables Affecting Response

1. Patient's insulin sensitivity - A 6-unit dose will have vastly different effects in an insulin-sensitive versus insulin-resistant patient 1

2. Baseline blood glucose level - Higher starting glucose allows for greater absolute reduction 2

3. Timing relative to meals - Actrapid should ideally be given 30 minutes before meals for optimal postprandial control 3

4. Residual beta-cell function - Patients with endogenous insulin production will have enhanced glucose-lowering effects 3

5. Body weight - Typical dosing ranges from 0.1-0.3 U/kg for basal insulin, so 6 units represents a moderate dose for most adults 1

Clinical Dosing Context

According to current guidelines 1, 2:

• For correction insulin: Regular insulin is typically dosed at 1 unit per 10-15 g of carbohydrate or based on insulin sensitivity factor
• For nutritional coverage: Starting doses of 1 unit per 10-15 g carbohydrate are standard 2
• 6 units represents: A reasonable prandial or correction dose for many patients

Time Course of Action

Regular human insulin (Actrapid) has the following pharmacokinetic profile:

• Onset: 30-60 minutes
• Peak effect: 2-4 hours
• Duration: 6-8 hours

This differs from rapid-acting analogs which act faster 3, 4. Studies demonstrate that Actrapid given 30 minutes before meals provides comparable postprandial control to rapid-acting analogs given immediately before eating 3.

Important Clinical Caveats

Risk of hypoglycemia exists, particularly if:

• The patient has not eaten adequate carbohydrates
• Baseline glucose is already low (<100 mg/dL)
• The patient has impaired renal function (reduces insulin clearance)
• There is increased physical activity
• Alcohol has been consumed 5, 6

Hypoglycemia should be treated with 15-20 g of glucose if blood glucose drops below 70 mg/dL (3.9 mmol/L) 5, 7. Recheck in 15 minutes and repeat treatment if needed.

Mixing Considerations

If mixing Actrapid with other insulins 8:

• Can be mixed with NPH (Protaphane) - minimal interaction
• Should NOT be mixed with lente insulins - zinc binding delays onset
• Should NOT be mixed with insulin glargine - incompatible pH 9

Bottom Line

Six units of Actrapid will definitively lower blood glucose in virtually all patients, with the degree of reduction varying based on individual factors. The key is ensuring appropriate carbohydrate intake to prevent hypoglycemia and timing the dose 30 minutes before meals for optimal effect 2, 3.